Clinical Trial Update: GILT Docetaxel - Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update for GILT Docetaxel in non-small cell lung cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• GILT Docetaxel (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Lung Neoplasms | Phase 3 | Status: COMPLETED